Results summary | View all lists in L2L MDB | View all genes in A07E.profile.u50 |
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 3.09-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
211731_X_AT | SSX3 | R | ![]() |
![]() |
synovial sarcoma, X breakpoint 3 | ||||||||
36829_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) | |||||||
220650_S_AT | SLC9A5 | T | ![]() |
![]() |
solute carrier family 9 (sodium/hydrogen exchanger), member 5 | ||||||||
206544_X_AT | SMARCA2 | G | R | ![]() |
![]() |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | |||||||
202861_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) |